These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 21971758)

  • 1. Increased oxidative damage and decreased antioxidant function in aging human substantia nigra compared to striatum: implications for Parkinson's disease.
    Venkateshappa C; Harish G; Mythri RB; Mahadevan A; Bharath MM; Shankar SK
    Neurochem Res; 2012 Feb; 37(2):358-69. PubMed ID: 21971758
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elevated oxidative stress and decreased antioxidant function in the human hippocampus and frontal cortex with increasing age: implications for neurodegeneration in Alzheimer's disease.
    Venkateshappa C; Harish G; Mahadevan A; Srinivas Bharath MM; Shankar SK
    Neurochem Res; 2012 Aug; 37(8):1601-14. PubMed ID: 22461064
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of markers of oxidative stress, antioxidant function and astrocytic proliferation in the striatum and frontal cortex of Parkinson's disease brains.
    Mythri RB; Venkateshappa C; Harish G; Mahadevan A; Muthane UB; Yasha TC; Srinivas Bharath MM; Shankar SK
    Neurochem Res; 2011 Aug; 36(8):1452-63. PubMed ID: 21484266
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alteration in glutathione content and associated enzyme activities in the synaptic terminals but not in the non-synaptic mitochondria from the frontal cortex of Parkinson's disease brains.
    Harish G; Mahadevan A; Srinivas Bharath MM; Shankar SK
    Neurochem Res; 2013 Jan; 38(1):186-200. PubMed ID: 23070472
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitative proteomic profiling of the rat substantia nigra places glial fibrillary acidic protein at the hub of proteins dysregulated during aging: Implications for idiopathic Parkinson's disease.
    Gómez-Gálvez Y; Fuller HR; Synowsky S; Shirran SL; Gates MA
    J Neurosci Res; 2020 Jul; 98(7):1417-1432. PubMed ID: 32270889
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Converging roles of ion channels, calcium, metabolic stress, and activity pattern of Substantia nigra dopaminergic neurons in health and Parkinson's disease.
    Duda J; Pötschke C; Liss B
    J Neurochem; 2016 Oct; 139 Suppl 1(Suppl Suppl 1):156-178. PubMed ID: 26865375
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glutathione, iron and Parkinson's disease.
    Bharath S; Hsu M; Kaur D; Rajagopalan S; Andersen JK
    Biochem Pharmacol; 2002 Sep; 64(5-6):1037-48. PubMed ID: 12213603
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Parkinson's disease is associated with oxidative damage to cytoplasmic DNA and RNA in substantia nigra neurons.
    Zhang J; Perry G; Smith MA; Robertson D; Olson SJ; Graham DG; Montine TJ
    Am J Pathol; 1999 May; 154(5):1423-9. PubMed ID: 10329595
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuroprotective effect of combined therapy with hyperbaric oxygen and madopar on 6-hydroxydopamine-induced Parkinson's disease in rats.
    Pan X; Chen C; Huang J; Wei H; Fan Q
    Neurosci Lett; 2015 Jul; 600():220-5. PubMed ID: 26101828
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effect of electroacupuncture intervention on levels of SOD, GSH, GSH-Px, MDA, and apoptosis of dopaminergic neurons in substantia Nigra in rats with Parkinson's disease].
    Li J; Wang LN; Xiao HL; Li X; Yang JJ
    Zhen Ci Yan Jiu; 2014 Jun; 39(3):185-91. PubMed ID: 25069193
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibitors of mitochondrial respiration, iron (II), and hydroxyl radical evoke release and extracellular hydrolysis of glutathione in rat striatum and substantia nigra: potential implications to Parkinson's disease.
    Han J; Cheng FC; Yang Z; Dryhurst G
    J Neurochem; 1999 Oct; 73(4):1683-95. PubMed ID: 10501216
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The evaluation of the changes in enzymatic antioxidant reserves and lipid peroxidation in chosen parts of the brain in an animal model of Parkinson disease.
    Romuk EB; Szczurek W; Oleś M; Gabrysiak A; Skowron M; Nowak P; Birkner E
    Adv Clin Exp Med; 2017 Sep; 26(6):953-959. PubMed ID: 29068596
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cholesterol contributes to dopamine-neuronal loss in MPTP mouse model of Parkinson's disease: Involvement of mitochondrial dysfunctions and oxidative stress.
    Paul R; Choudhury A; Kumar S; Giri A; Sandhir R; Borah A
    PLoS One; 2017; 12(2):e0171285. PubMed ID: 28170429
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low Levels of Prohibitin in Substantia Nigra Makes Dopaminergic Neurons Vulnerable in Parkinson's Disease.
    Dutta D; Ali N; Banerjee E; Singh R; Naskar A; Paidi RK; Mohanakumar KP
    Mol Neurobiol; 2018 Jan; 55(1):804-821. PubMed ID: 28062948
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alterations in m-RNA expression for Cu,Zn-superoxide dismutase and glutathione peroxidase in the basal ganglia of MPTP-treated marmosets and patients with Parkinson's disease.
    Kunikowska G; Jenner P
    Brain Res; 2003 Apr; 968(2):206-18. PubMed ID: 12663090
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glutathione depletion in PC12 results in selective inhibition of mitochondrial complex I activity. Implications for Parkinson's disease.
    Jha N; Jurma O; Lalli G; Liu Y; Pettus EH; Greenamyre JT; Liu RM; Forman HJ; Andersen JK
    J Biol Chem; 2000 Aug; 275(34):26096-101. PubMed ID: 10846169
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Omega-3 deficiency and neurodegeneration in the substantia nigra: involvement of increased nitric oxide production and reduced BDNF expression.
    Cardoso HD; dos Santos Junior EF; de Santana DF; Gonçalves-Pimentel C; Angelim MK; Isaac AR; Lagranha CJ; Guedes RC; Beltrão EI; Morya E; Rodrigues MC; Andrade-da-Costa BL
    Biochim Biophys Acta; 2014 Jun; 1840(6):1902-12. PubMed ID: 24361617
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Brain monoamine oxidase B and A in human parkinsonian dopamine deficiency disorders.
    Tong J; Rathitharan G; Meyer JH; Furukawa Y; Ang LC; Boileau I; Guttman M; Hornykiewicz O; Kish SJ
    Brain; 2017 Sep; 140(9):2460-2474. PubMed ID: 29050386
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of eldepryl on glial cell proliferation and activation in the substantia nigra and striatum in a rat model of Parkinson's disease.
    Liu B; Lv C; Zhang J; Liu Y; Sun J; Cheng X; Mao W; Ma Y; Li S
    Neurol Res; 2017 May; 39(5):459-467. PubMed ID: 28276259
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glycyrrhizic acid Attenuates Neuroinflammation and Oxidative Stress in Rotenone Model of Parkinson's Disease.
    Ojha S; Javed H; Azimullah S; Abul Khair SB; Haque ME
    Neurotox Res; 2016 Feb; 29(2):275-87. PubMed ID: 26607911
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.